Poster 63
- Kelley Tangredi
- May 3, 2023
- 1 min read
Updated: Jul 8, 2023
Efficacy and Safety of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus
Authors: Andrew Blauvelt, Zoe Draelos, Melinda Gooderham, Edward Lain, Angela Moore, Kim Papp, Matthew Zirwas, David Krupa, Patrick Burnett, David Berk, David Chu
Comentarios